kidney stones. Calculus of kidney
Conditions
Interventions
Intervention 1: The intervention group 1 will receive indapamide, 2.5 mg daily. Intervention 2: The intervention group 2 will receive hydrochlorothiazide 50 mg daily. Intervention 3: The control grou
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age18 to 70 years The patient is a candidate for TUL Providing consent to enter the study
Exclusion criteria
Exclusion criteria: Pregnancy or breastfeeding History of allergy to any of the study drugs Concomitant use of other diuretics Prohibition of use of any of the study drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The diameter of the remaining stone particles in the ureter. Timepoint: Periodically for three months. Method of measurement: Ultrasound of patients.;Serum creatinine level. Timepoint: Periodically for three months. Method of measurement: Blood test.;Systolic and diastolic blood pressure. Timepoint: Periodically for three months. Method of measurement: Sphygmomanometer.;Severity of hydronephrosis before and after surgery. Timepoint: Periodically for three months. Method of measurement: Ultrasound.;Glomerular filtration. Timepoint: Periodically for three months. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Mohsen Zabihi
Yazd University of Medical Sciences
Outcome results
None listed